Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:Company
|
| gptkbp:bfsLayer |
3
|
| gptkbp:bfsParent |
gptkb:comic_book
|
| gptkbp:awards |
Best Startup Award 2018
|
| gptkbp:clinical_trial |
ongoing
|
| gptkbp:collaborations |
international pharmaceutical companies
|
| gptkbp:employees |
50-100
|
| gptkbp:focus |
oncology
autoimmune diseases infectious diseases |
| gptkbp:founded |
gptkb:2015
|
| gptkbp:founder |
Dr. Thomas H. H. Huber
|
| gptkbp:headquarters |
gptkb:Berlin,_Germany
|
| https://www.w3.org/2000/01/rdf-schema#label |
Phase Six
|
| gptkbp:industry |
gptkb:drug
|
| gptkbp:mission |
improve patient outcomes
|
| gptkbp:partnerships |
various research institutions
|
| gptkbp:products |
pharmaceutical compounds
|
| gptkbp:receives_funding_from |
Series A funding
Series B funding |
| gptkbp:specializes_in |
drug development
|
| gptkbp:vision |
leading innovator in pharmaceuticals
|
| gptkbp:website |
www.phasesix.com
|